CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Thursday reported a loss of $66 million in its second quarter.
The Carlsbad, California-based company said it had a loss of 45 cents per share.
The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 95 cents per share.
The drug discovery and development company posted revenue of $225 million in the period, also exceeding Street forecasts. Nine analysts surveyed by Zacks expected $147.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
